Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-cai
/
Caris Life Sciences Inc
CAI
33.660
USD
+0.540
+1.63%
Close 09/16, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 09/17, 09:30 (ET)
9.46B
Market Cap
Loss
P/E TTM
Caris Life Sciences Inc
33.660
+0.540
+1.63%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
--
7.29M
--
-31.34M
Net income from continuing operations
--
-71.79M
--
-102.58M
Operating gains losses
--
6.41M
--
7.04M
Other non-cash items
--
27.94M
--
3.85M
Change in working capital
--
-1.44M
--
13.32M
-Change in receivables
--
29.13M
--
7.91M
-Change in inventory
--
-4.68M
--
2.06M
-Change in prepaid expenses
--
-4.74M
--
2.47M
-Change in other current assets
--
298.00K
--
36.00K
Cash from non-recurring investing activities
Cash from operating activities
--
7.29M
--
-31.34M
Investing cash flow
Net cash from continuing investing activities
--
1.39M
--
2.69M
Capital expenditures
--
1.39M
--
2.69M
Net cash flow from disposal of fixed assets
--
1.39M
--
2.69M
Net cash flow from investment products
--
0.00
--
0.00
Cash from non-current investing activities
Net cash flow from investing activities
--
-1.39M
--
-2.69M
Financing cash flow
Cash flow from continuous financing activities
--
681.40M
--
1.28M
Net cash flow from debt Issuance/repayment
--
23.84M
--
-22.00K
Net cash flow from common stock issuance/repurchase
--
528.46M
--
-22.00K
Net cash flow from preferred stock issuance/repurchase
--
121.24M
--
--
Proceeds from stock option exercised by employees
--
1.19M
--
1.43M
Proceeds from issuance of warrants
--
10.27M
--
--
Net cash flow from other financing activities
--
-3.60M
--
-105.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--
681.40M
--
1.28M
Net cash flow
Beginning cash balance
--
35.29M
--
68.03M
Current period cash flow changes
--
687.40M
--
-32.74M
Effect of exchange rate changes
--
93.00K
--
4.00K
Ending cash balance
--
722.69M
--
35.29M
Free cash flow
--
5.90M
--
-34.03M
Currency unit
USD
USD
Audit opinions
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up